Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH AntagonistHugh S. Taylor, Kristof Chwalisż, Linda C. Giudice et al.|New England Journal of Medicine|2017Cited by 492
Long-Term Outcomes of Elagolix in Women With EndometriosisEric S. Surrey, Kristof Chwalisż, Hugh S. Taylor et al.|Obstetrics and Gynecology|2018Cited by 132
Elinzanetant for the Treatment of Vasomotor Symptoms Associated With MenopauseJoAnn V. Pinkerton, Lineke Zuurman, Nazanin Haseli Mashhadi et al.|JAMA|2024Cited by 90
Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy menstrual bleeding and uterine fibroids: a post hoc analysis of data from two clinical trialsJames A. Simon, Michael C. Snabes, Elizabeth A. Stewart et al.|F&S Reports|2024Cited by 1
Elagolix With Add-Back Rapidly Improves Nonbleeding Symptoms in Individuals With Fibroid-Associated Heavy Menstrual Bleeding [ID: 1368052]James A. Simon, Brett Pinsky, Susan Jewell et al.|Obstetrics and Gynecology|2023Cited by 0